Dosage and administration
apply to underarms only shake well before each use hold can about 6 inches away from underarm and spray.
apply to underarms only shake well before each use hold can about 6 inches away from underarm and spray.
Aluminum Chlorohydrate 10% (anhydrous)
Antiperspirant
Reduces underarm wetness
For external use only.
Flammable
On broken skin
if you have kidney disease
if rash or irritation occurs
If swallowed, get medical help or contact a Poison Control Center right away.
Butane, Hydrofluorocarbon 152a, Cyclopentasiloxane, Isopropyl Myristate, Dimethicone, Disteardimonium Hectorite, Propylene Carbonate, Ethylene Brassylate
1-800-487-7273
www.suredeodorant.com
SURE ®
UNSCENTED
aerosol
ANTI-PERSPIRANT
DEODORANT
Net Wt 6 oz (170g)
© Idelle Labs, Ltd. All rights reserved
Made in the Canada and distributed by Idelle Labs, Ltd., El Paso, TX 79912
Sure ® is a registered trademark of Kaz Europe Sarl.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 41595-5517-6 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-90be-f424-e053-dadaa90a57ce | Sure Antiperspirant Deodorant Unscented |
| 41595-5517-6 | 2021-06-16 | C162847 | 48780-1 | 9d75b9d0-90be-f424-e053-dadaa90a57ce | Sure Antiperspirant Deodorant Unscented |
| 41595-5517-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-90be-f424-e053-dadaa90a57ce | Sure Antiperspirant Deodorant Unscented |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41595-5517-6 | Sure Antiperspirant Deodorant Unscented | 170 g in 1 CAN | AEROSOL | 170 | 9 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41595-5517 | SURE ANTIPERSPIRANT DEODORANT UNSCENTED (ALUMINUM CHLOROHYDRATE) AEROSOL [IDELLE LABS, LTD] | 9 | Legacy NDC, 1 package rows | 20230121_9d832eed-4ff5-455f-8678-a65d4e8d8c71.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALUMINUM CHLOROHYDRATE | ACTIVE INGREDIENT | HPN8MZW13M | 6 | |
| ALUMINUM CHLOROHYDRATE | ACTIVE MOIETY | HPN8MZW13M | 6 | |
| BUTANE | INACTIVE INGREDIENT | 6LV4FOR43R | 6 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 6 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 6 | |
| ETHYLENE BRASSYLATE | INACTIVE INGREDIENT | 9A87HC7ROD | 6 | |
| HECTORITE | INACTIVE INGREDIENT | 08X4KI73EZ | 6 | |
| ISOPROPYL MYRISTATE | INACTIVE INGREDIENT | 0RE8K4LNJS | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41595-5517 | 41595-5517-6 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BUTANE | 6LV4FOR43R | IACT |
| 1,1-DIFLUOROETHANE | 0B1U8K2ME0 | IACT |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
| ISOPROPYL MYRISTATE | 0RE8K4LNJS | IACT |
| DIMETHICONE | 92RU3N3Y1O | IACT |
| DISTEARDIMONIUM HECTORITE | X687XDK09L | IACT |
| PROPYLENE CARBONATE | 8D08K3S51E | IACT |
| ETHYLENE BRASSYLATE | 9A87HC7ROD | IACT |
| ALUMINUM CHLOROHYDRATE | HPN8MZW13M | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | SUSPENSION / AURICULAR (OTIC) | 0.02 %w/w | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | FILM / TRANSDERMAL | 58.08 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | CREAM / TOPICAL | 65000 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | LOTION / TOPICAL | 50 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL / TRANSDERMAL | 85 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL / TOPICAL | 29 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | CREAM / VAGINAL | 50 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | SPRAY / TOPICAL | 3665 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL, METERED / TRANSDERMAL | 50 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL / TOPICAL | NA | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | SYSTEM / TRANSDERMAL | 113 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL / TOPICAL | 9.3 %w/w | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | OIL / AURICULAR (OTIC) | 36 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | OIL / TOPICAL | 213 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL, SPRAY / TOPICAL | 6.89 %w/w | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL, FOAM / TOPICAL | 27 %w/w | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | SYSTEM / TOPICAL | 7 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | OINTMENT / TOPICAL | 35 %w/w | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | FILM, EXTENDED RELEASE / TRANSDERMAL | 20.4 mg | ||
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL, FOAM / RECTAL | 12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f2b354b4-2a9b-6c41-e053-2a95a90a7891 | 9d832eed-4ff5-455f-8678-a65d4e8d8c71 | 2023-01-02 | Warnings | f2b354b4-2a9b-6c41-e053-2a95a90a7891 9d832eed-4ff5-455f-8678-a65d4e8d8c71 |
Adverse event summaries are temporarily unavailable. Other product information remains available.